Ledger.Open graph →
SEC Form D · filed October 13, 2020

Olema Pharmaceuticals, Inc

Offering
$87.4M
Sold
$87.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Shane Kovacs · San Francisco, CAExecGraham Walmsley · South San Francisco, CADirectorAndrew Rappaport · San Francisco, CADirectorCyrus Harmon · Berkeley, CAExec · DirectorPeter Kushner · San Francisco, CAExecKinney Horn · San Francisco, CAExecDavid Myles · San Francisco, CAExecFrank Mccormick · South San Francisco, CADirectorGorjan Hrustanovic · Newark, CADirectorIan Clark · Tuckahoe, NYDirectorCynthia Butitta · San Francisco, CADirectorSean Bohen · San Francisco, CAExec · DirectorJohn Moriarty · San Francisco, CAExecPeter Kushner · San Francisco, CAExecKinney Horn · San Francisco, CAExecDavid Myles · San Francisco, CAExecShane Kovacs · San Francisco, CAExecGraham Walmsley · South San Francisco, CADirectorAndrew Rappaport · Carlsbad, CADirectorFrank Mccormick · Berkeley, CADirectorGorjan Hrustanovic · San Francisco, CADirectorCyrus Harmon · San Francisco, CAExec · DirectorIan Clark · New Rochelle, NYDirectorCynthia Butitta · San Francisco, CADirectorSean Bohen · San Francisco, CAExec · DirectorJohn Moriarty · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗